FIELD: pharmaceutical chemistry.
SUBSTANCE: invention relates to treatment of patients suffering from diseases associated with pathologic activity of matrix proteases. Treatment involves administration of compounds depicted by general formula (I).
EFFECT: increased treatment efficiency.
136 cl, 448 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PERACUTE, CHRONIC AND SUBACUTE COUGH AND IRRESISTIBLE DESIRE TO CLEAR THROAT | 2014 |
|
RU2650118C2 |
COMPOUNDS AND COMPOSITIONS AS TRO MIMETICS | 2006 |
|
RU2385865C2 |
HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S TRANSPORTATION INHIBITORS | 2005 |
|
RU2424239C2 |
MACROCYCLIC PEPTIDES ELICITING ACTIVITY WITH RESPECT TO HEPATITIS C VIRUS | 2000 |
|
RU2247126C2 |
ALTERNATIVE METHODS FOR SYNTHESIS OF RENIN INHIBITORS AND INTERMEDIATE COMPOUNDS THEREOF | 2005 |
|
RU2411230C2 |
COMPOUNDS AND COMPOSITIONS AS PROTEINKINASE INHIBITORS | 2006 |
|
RU2411242C2 |
SERINE PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITION AND THERAPEUTICAL METHODS BASED ON THE SAME | 2000 |
|
RU2252935C2 |
ARYLSULFONYL DERIVATIVES POSSESSING AFFINITY TO 5-HT RECEPTOR AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2268884C2 |
6-AMINO-2-SUBSTITUTED-5-VINYLSILYLPYRIMIDINE-4-CARBOXYLIC ACIDS AND ESTERS AND 4-AMINO-6-SUBSTITUTED-3-VINYLSILYLPYRIMIDINE-PICOLINIC ACIDS AND ESTERS AS HERBICIDES | 2012 |
|
RU2556000C2 |
NON-NUCLEOSIDE REVERSE TRANCRIPTASE INHIBITORS, USES THEREOF, PHARMACEUTICAL COMPOSITION FOR HIV INHIBITION | 2004 |
|
RU2305680C2 |
Authors
Dates
2005-04-20—Published
1998-11-12—Filed